Ordering Recommendation

Determine the patient's blood type (ABO and Rh D) in prenatal patients only, to evaluate possible risk for hemolytic disease of the fetus and newborn (HDFN) and to evaluate if the patient is a candidate for Rh Immunoglobulin. 

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lavender (K2EDTA) or Pink (K2EDTA).

Specimen Preparation

Transport 7 mL whole blood. (Min: 3 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions
Remarks
Stability

Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable

Methodology

Hemagglutination

Performed

Mon-Fri

Reported

1-3 days

Reference Interval

ABO Typing: A, B, AB, O
Rh Typing: Rh positive/Rh negative

Interpretive Data



Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

86900; 86901

Components

Component Test Code* Component Chart Name LOINC
0010016 ABORh Prenatal 882-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Blood Type, Prenatal
ABO-Rh Prenatal